HOME › DRUGS › MOXETUMOMAB PASUDOTOX
ACTIVE SUBSTANCE / INN

MOXETUMOMAB PASUDOTOX

Brand name(s): Lumoxiti
EMA LISTED
WITHDRAWN
Leukemia, Hairy Cell
ACTIVE SUBSTANCE
Moxetumomab Pasudotox
REGULATORS
EMA
SPONSORS / MAH
AstraZeneca AB
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
LumoxitiAstraZeneca ABWithdrawn08/02/2021Leukemia, Hairy Cell

FULL INTELLIGENCE ON MOXETUMOMAB PASUDOTOX

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →